Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Activation of EGFR by proteasome inhibition requires HB-EGF in pancreatic cancer cells.

Activation of EGFR by proteasome inhibition requires HB-EGF in pancreatic cancer cells. Oncogene. 2010 May 27; 29(21):3146-52.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.